Developer docs
API playgroundTry for free, no card

Search company profiles

LKC Technologies, Inc. (LKC)

Full company profile

uuid0004jrt

Namestring
LKC Technologies, Inc. (LKC)
Legal namestring
LKC Technologies, Inc.
Websiteurl
lkc.com
Company typeenum
Private
Founded yearint
1975
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGaithersburg, United States
HQ citystring
Gaithersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electroretinography devices, visual electrophysiology equipment, ophthalmic diagnostic devices, retinal function testing, medical device manufacturing
NAICS code1 code
  • 334510
SIC code1 code
  • 3845
Product category
Ophthalmic Diagnostic Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales (Capital Equipment)
TypeHardware Sales
Description

Sale of RETeval, UTAS, and RETevet electrophysiology testing devices to ophthalmology and optometry practices, hospitals, and research institutions. One-time capital purchase of the device hardware.

lkc.com
2Consumables (Sensor Strips)
TypeHardware Sales
Description

Sale of disposable sensor strip electrodes and other consumable supplies for the RETeval and RETevet devices. Recurring consumable revenue from installed device base.

lkc.com
3Software/Firmware
TypeOne Time License
Description

Software embedded in devices; 1-year warranty on software/firmware performance per published specifications. Software licenses are granted as interim licenses pending full payment.

lkc.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Device hardware pricing — not publicly disclosed
ModelOtherBilling cadencePay-as-you-go
Notes

LKC does not publicly list device pricing. Contact sales / quote-based. Standard payment terms: prior to product shipment in U.S. dollars.

lkc.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1RETeval
Description

FDA-cleared, portable, battery-powered, non-mydriatic ERG/VEP Testing Device for retinal function assessment

lkc.com
+3 more records
Core offering1 text field

LKC Technologies designs, manufactures, and sells visual electrophysiology medical devices, primarily electroretinography (ERG) and visual evoked potential (VEP) systems used by eye care professionals to objectively measure retinal function. Its flagship RETeval is the only FDA-cleared, portable, battery-powered, non-mydriatic handheld ERG/VEP device on the market, complemented by the UTAS desktop mf/PERG system, the RETevet veterinary variant, and patented disposable sensor strip electrodes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • A RETeval DR Score of 26.9 or higher outperformed OCT-A, ultra-widefield FA, and fundus photography in identifying which patients with moderate to severe NPDR would progress to vision-threatening complications within 1 year (November 2025 study from Ophthalmology Science)
+5 more records
Product overview1 text field

LKC Technologies offers a portfolio of visual electrophysiology devices centered on electroretinography (ERG) and visual evoked potential (VEP) testing. The core product line consists of the RETeval handheld device (FDA-cleared portable ERG/VEP system for human clinical use), RETevet (veterinary variant), UTAS mf/PERG (full-featured desktop system for multifocal and pattern ERG), and Sensor Strips (patented skin-electrode accessories). These products span human ophthalmology, veterinary ophthalmology, and research applications, enabling objective retinal function assessment without requiring pupil dilation in many cases.

Product and service4 records
1RETeval
CategoryCore product — handheld ERG/VEP device
Description

FDA-cleared, portable, battery-powered, non-mydriatic ERG/VEP testing device used by ophthalmologists, optometrists, and research institutions for objective retinal function assessment in human patients.

2RETevet
CategoryCore product — veterinary ERG device
Description

Veterinary-specific handheld ERG device for measuring animal retinal function with a real-time view of the eye, designed for veterinary ophthalmologists and animal researchers.

3UTAS mf/PERG
CategoryCore product — desktop mf/PERG system
Description

Desktop testing system for multifocal and pattern ERG and VEP assessments with an intuitive interface, used in clinical and research settings requiring comprehensive electrophysiology testing.

4LKC Sensor Strips
CategoryAccessory — consumable electrode array
Description

Patented electrode array that adheres to the skin beneath the eye rather than touching the eye, used to perform non-invasive electroretinography testing with RETeval and RETevet devices.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Germany-based developer of ERG, VEP, and multifocal ERG devices for clinical and research ophthalmology. Closely overlaps LKC's UTAS and RETeval offerings, especially in European academic and specialty practice accounts.

TypeBroad incumbent
Description

Established ophthalmic imaging incumbent best known for Spectralis OCT platforms. Competes for diagnostic budget in retinal disease management but does not offer a handheld ERG equivalent, making it adjacent rather than head-to-head with RETeval.

TypeBroad incumbent
Description

Major ophthalmic equipment manufacturer with broad diagnostic, imaging, and refraction portfolios. Overlaps LKC in eye-care professional accounts but focuses on structural imaging and refraction rather than electrophysiology.

TypeBroad incumbent
Description

Japanese ophthalmic equipment maker with diagnostic, laser, and refraction offerings. Sells into similar optometry/ophthalmology channels as LKC but does not field a competitive handheld ERG/VEP system.

TypeDirect peer
Description

Specialist in ophthalmic diagnostics including multifocal ERG (formerly via the Espion product line acquired by Konan). Competes head-to-head with LKC's UTAS mf/PERG in clinical and research electrophysiology installations.

TypeEmerging player
Description

Developer of AdaptDx dark adaptation testing for early AMD detection. Targets the same functional-testing paradigm as RETeval in optometry channels but with a different clinical modality, making it a thematic emerging peer rather than direct competitor.

TypeDirect peer
Description

French manufacturer of visual electrophysiology equipment including ERG, VEP, and EOG systems. Directly comparable product portfolio to LKC, focused on ophthalmology and research customers in Europe and emerging markets.

TypeDirect peer
Description

Direct competitor in clinical visual electrophysiology, manufacturing ERG and VEP systems for ophthalmology and research. Offers desktop and handheld units that overlap directly with LKC's UTAS and RETeval product lines.

TypeOthers
Description

Sister company under AMETEK's Electronic Instruments Group that LKC now joins. Reichert provides tonometers, refractors, and other ophthalmic instruments; not a competitor but a distribution and portfolio integration channel post-acquisition.

TypeBroad incumbent
Description

Large diversified ophthalmic device company spanning OCT, perimetry, fundus imaging, and surgical microscopes. Adjacent competitor for diagnostic spend in retinal and glaucoma care; broader portfolio but no direct handheld ERG device.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LKC Technologies, Inc. (LKC)

Ophthalmic Diagnostic Deviceslkc.com

LKC Technologies, Inc. (LKC) firmographics

Firmographics
Name
LKC Technologies, Inc. (LKC)
Legal name
LKC Technologies, Inc.
Website
https://lkc.com
Company type
Private
Founded year
1975
Operating status
Acquired
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where LKC Technologies, Inc. (LKC) is headquartered

Location

Headquarters

HQ city
Gaithersburg
HQ country
United States
HQ region
North America

Offices2 records

Markets served

LKC Technologies, Inc. (LKC) business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales (Capital Equipment): Sale of RETeval, UTAS, and RETevet electrophysiology testing devices to ophthalmology and optometry practices, hospitals, and research institutions. One-time capital purchase of the device hardware.
  2. Consumables (Sensor Strips): Sale of disposable sensor strip electrodes and other consumable supplies for the RETeval and RETevet devices. Recurring consumable revenue from installed device base.
  3. Software/Firmware: Software embedded in devices; 1-year warranty on software/firmware performance per published specifications. Software licenses are granted as interim licenses pending full payment.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goDevice hardware pricing — not publicly disclosed

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

LKC Technologies, Inc. (LKC) product offering

Product offering

Core offering

LKC Technologies designs, manufactures, and sells visual electrophysiology medical devices, primarily electroretinography (ERG) and visual evoked potential (VEP) systems used by eye care professionals to objectively measure retinal function. Its flagship RETeval is the only FDA-cleared, portable, battery-powered, non-mydriatic handheld ERG/VEP device on the market, complemented by the UTAS desktop mf/PERG system, the RETevet veterinary variant, and patented disposable sensor strip electrodes.

Product overview

LKC Technologies offers a portfolio of visual electrophysiology devices centered on electroretinography (ERG) and visual evoked potential (VEP) testing. The core product line consists of the RETeval handheld device (FDA-cleared portable ERG/VEP system for human clinical use), RETevet (veterinary variant), UTAS mf/PERG (full-featured desktop system for multifocal and pattern ERG), and Sensor Strips (patented skin-electrode accessories). These products span human ophthalmology, veterinary ophthalmology, and research applications, enabling objective retinal function assessment without requiring pupil dilation in many cases.

Differentiator

Problem solved

Functional benefit

Brands

  • RETeval: FDA-cleared, portable, battery-powered, non-mydriatic ERG/VEP Testing Device for retinal function assessment
  • RETevet
  • UTAS
  • LKC Sensor Strips

Products and services

  • RETeval FDA-cleared, portable, battery-powered, non-mydriatic ERG/VEP testing device used by ophthalmologists, optometrists, and research institutions for objective retinal function assessment in human patients.
  • RETevet Veterinary-specific handheld ERG device for measuring animal retinal function with a real-time view of the eye, designed for veterinary ophthalmologists and animal researchers.
  • UTAS mf/PERG Desktop testing system for multifocal and pattern ERG and VEP assessments with an intuitive interface, used in clinical and research settings requiring comprehensive electrophysiology testing.
  • LKC Sensor Strips Patented electrode array that adheres to the skin beneath the eye rather than touching the eye, used to perform non-invasive electroretinography testing with RETeval and RETevet devices.

Quantifiable outcome

  • A RETeval DR Score of 26.9 or higher outperformed OCT-A, ultra-widefield FA, and fundus photography in identifying which patients with moderate to severe NPDR would progress to vision-threatening complications within 1 year (November 2025 study from Ophthalmology Science)
  • +5 more outcomes

Companies that use LKC Technologies, Inc. (LKC)

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

LKC Technologies, Inc. (LKC) technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

LKC Technologies, Inc. (LKC) partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

LKC Technologies, Inc. (LKC) competitors and assessment

Company assessment

Direct peers

  • Roland Consult: Germany-based developer of ERG, VEP, and multifocal ERG devices for clinical and research ophthalmology. Closely overlaps LKC's UTAS and RETeval offerings, especially in European academic and specialty practice accounts.
  • Konan Medical: Specialist in ophthalmic diagnostics including multifocal ERG (formerly via the Espion product line acquired by Konan). Competes head-to-head with LKC's UTAS mf/PERG in clinical and research electrophysiology installations.
  • Metrovision: French manufacturer of visual electrophysiology equipment including ERG, VEP, and EOG systems. Directly comparable product portfolio to LKC, focused on ophthalmology and research customers in Europe and emerging markets.
  • Diagnosys LLC: Direct competitor in clinical visual electrophysiology, manufacturing ERG and VEP systems for ophthalmology and research. Offers desktop and handheld units that overlap directly with LKC's UTAS and RETeval product lines.

Broad incumbents

  • Heidelberg Engineering: Established ophthalmic imaging incumbent best known for Spectralis OCT platforms. Competes for diagnostic budget in retinal disease management but does not offer a handheld ERG equivalent, making it adjacent rather than head-to-head with RETeval.
  • Topcon Healthcare: Major ophthalmic equipment manufacturer with broad diagnostic, imaging, and refraction portfolios. Overlaps LKC in eye-care professional accounts but focuses on structural imaging and refraction rather than electrophysiology.
  • Nidek Co., Ltd. Japanese ophthalmic equipment maker with diagnostic, laser, and refraction offerings. Sells into similar optometry/ophthalmology channels as LKC but does not field a competitive handheld ERG/VEP system.
  • Carl Zeiss Meditec: Large diversified ophthalmic device company spanning OCT, perimetry, fundus imaging, and surgical microscopes. Adjacent competitor for diagnostic spend in retinal and glaucoma care; broader portfolio but no direct handheld ERG device.

Emerging players

  • MacuLogix: Developer of AdaptDx dark adaptation testing for early AMD detection. Targets the same functional-testing paradigm as RETeval in optometry channels but with a different clinical modality, making it a thematic emerging peer rather than direct competitor.

Others

  • Reichert Technologies (AMETEK): Sister company under AMETEK's Electronic Instruments Group that LKC now joins. Reichert provides tonometers, refractors, and other ophthalmic instruments; not a competitor but a distribution and portfolio integration channel post-acquisition.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

LKC Technologies, Inc. (LKC) social profiles

Digital presence

LKC Technologies, Inc. (LKC) compliance and trust

Trust signal

Compliance5 records

LKC Technologies, Inc. (LKC) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LKC Technologies, Inc. (LKC) leadership team

Management profile

Number of profiles

Profiles7 records

LKC Technologies, Inc. (LKC) funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LKC Technologies, Inc. (LKC) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LKC Technologies, Inc. (LKC)

What does LKC Technologies, Inc. (LKC) do?

LKC Technologies designs, manufactures, and sells visual electrophysiology medical devices, primarily electroretinography (ERG) and visual evoked potential (VEP) systems used by eye care professionals to objectively measure retinal function. Its flagship RETeval is the only FDA-cleared, portable, battery-powered, non-mydriatic handheld ERG/VEP device on the market, complemented by the UTAS desktop mf/PERG system, the RETevet veterinary variant, and patented disposable sensor strip electrodes.

Is LKC Technologies, Inc. (LKC) a public or private company?

LKC Technologies, Inc. (LKC) is a private company. It is classified as corporate owned and is currently acquired.

When was LKC Technologies, Inc. (LKC) founded?

LKC Technologies, Inc. (LKC) was founded in 1975. It employs 11 to 50 people.

Where is LKC Technologies, Inc. (LKC) based?

LKC Technologies, Inc. (LKC) is headquartered in Gaithersburg, United States, in the North America region.

How does LKC Technologies, Inc. (LKC) make money?

Three revenue lines are on record. Medical Device Sales (Capital Equipment) is the primary driver. The others are consumables (Sensor Strips) and software/Firmware.

Who are LKC Technologies, Inc. (LKC)'s main competitors?

Direct peers on record are Roland Consult, Konan Medical, Metrovision and Diagnosys LLC. Broad incumbents are Heidelberg Engineering, Topcon Healthcare, Nidek Co., Ltd. and Carl Zeiss Meditec. MacuLogix is listed as an emerging player. Reichert Technologies (AMETEK) is listed as an others.

Does LKC Technologies, Inc. (LKC) have an API?

No public API is recorded for LKC Technologies, Inc. (LKC).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLKC Technologies publie un protocole PhNR amélioré pour un test et un suivi objectifs du glaucomeLKC Technologies announced the publication of an enhanced photopic negative response (PhNR) protocol for its RETeval® device, a portable full-field electroretinography (ERG) system FDA-cleared for glaucoma testing and monitoring. The new algorithm improves test-retest variability by a factor of four and reduces the normative reference range by a factor of 1.7, providing clinicians with a more sensitive tool for detecting abnormal retinal ganglion cell function. The protocol requires no corneal contact, dilation, or anesthetic for most tests, making objective glaucoma assessment more accessible in clinical settings.PR NewswireLKC Technologies führt erweitertes PhNR-Protokoll für verbesserte, objektive Glaukomtests und -verfolgung einLKC Technologies, headquartered in Gaithersburg, Maryland, announced an improved photopic negative response (PhNR) protocol for its FDA-cleared RETeval® handheld full-field ERG device, coinciding with Glaucoma Awareness Month. The new algorithm delivers a fourfold improvement in test-retest variability and a 1.7-fold narrower normative reference range, enhancing sensitivity in detecting retinal ganglion cell dysfunction. The non-invasive protocol requires no corneal contact, dilation, or anesthesia, and is intended to support earlier glaucoma detection and disease monitoring.PR NewswireLKC Technologies lanza el protocolo PhNR mejorado para el glaucomaLKC Technologies announced the launch of an improved PhNR protocol for its FDA-approved RETeval® device, designed to enhance objective testing and monitoring for glaucoma. The updated algorithm offers a fourfold improvement in test-retest variability and a 1.7 times narrower normative reference range, resulting in greater sensitivity for detecting ganglion cell dysfunction. This development aims to address limitations in traditional subjective perimetry and image-based assessments.PR NewswireLKC Technologies Launches Enhanced PhNR Protocol for Improved, Objective Glaucoma Testing and TrackingLKC Technologies announced the release of an enhanced PhNR protocol for its RETeval Device, a portable electroretinography tool cleared by the FDA. This update improves test/retest variability by four times and narrows the normative reference range to provide more objective detection of glaucoma. The enhancement aims to aid clinicians in tracking retinal ganglion cell function without requiring dilation or anesthetics.PR NewswireLKC Technologies anuncia aprovação da agência reguladora de saúde brasileira para o sistema UTAS®LKC Technologies announced that Brazil's health regulatory agency ANVISA granted approval for the UTAS® ophthalmic electrophysiology medical device system. The company is partnering with OCULUS Brasil, its exclusive distributor in the country, to make the UTAS system and RETeval device more widely available to eye care professionals. The UTAS system offers flash and pattern ERG, VEP, and EOG capabilities compliant with ISCEV standards, with over 600 published scientific studies supporting its use across 45 years of development.PR NewswireLKC Technologies, Inc. Announces the Availability of Integrated Normative Data on its RETeval® DeviceLKC Technologies announced the release of software version 2.8.0 for its RETeval device, which now integrates age-adjusted normative data derived from the REACT clinical trial. This update provides physicians with reference intervals to aid in interpreting full function ERG test results, aiming to streamline workflow integration in clinical settings.PR NewswireLKC Technologies' Portable RETeval™ Electrodiagnostic Device and Sensor Strips Earn Two United States PatentsLKC Technologies received two United States patents for its RETeval™ electrodiagnostic device and associated Sensor Strip skin electrode arrays in late 2016. The patents cover the device's exclusive stimulus generation technology and the specific design of its non-invasive skin electrodes. These innovations aim to improve the accuracy, ease of use, and patient comfort in visual electrophysiology testing for conditions like glaucoma.